Therapeutics

Results: 5894



#Item
1April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

Add to Reading List

Source URL: www.herbal-ahp.org

Language: English - Date: 2018-04-13 15:31:29
    2Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

    Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

    Add to Reading List

    Source URL: microcapresearch.com

    Language: English - Date: 2016-08-30 19:31:41
      3  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

        Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

      Add to Reading List

      Source URL: www.warpdrivebio.com

      Language: English - Date: 2016-10-17 10:04:43
        4Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

        Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

        Add to Reading List

        Source URL: www.warpdrivebio.com

        Language: English - Date: 2018-03-13 18:27:46
          5Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

          Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

          Add to Reading List

          Source URL: www.daytrana.com

          Language: English - Date: 2016-02-25 12:18:23
            6ANTISENSE THERAPEUTICS LIMITED AUDIT COMMITTEE CHARTER This Charter governs the operations of the Audit Committee (‘Committee’). The Committee shall review and reassess the Charter at least annually and obtain the ap

            ANTISENSE THERAPEUTICS LIMITED AUDIT COMMITTEE CHARTER This Charter governs the operations of the Audit Committee (‘Committee’). The Committee shall review and reassess the Charter at least annually and obtain the ap

            Add to Reading List

            Source URL: www.antisense.com.au

            Language: English - Date: 2017-01-23 18:20:22
              7ANTISENSE THERAPEUTICS LIMITED COMMUNICATIONS POLICY Communications to Investors & Other Market Participants The purpose of this policy is to describe the process by which Antisense Therapeutics communicates with its inv

              ANTISENSE THERAPEUTICS LIMITED COMMUNICATIONS POLICY Communications to Investors & Other Market Participants The purpose of this policy is to describe the process by which Antisense Therapeutics communicates with its inv

              Add to Reading List

              Source URL: 43.229.63.250

              Language: English - Date: 2017-01-23 18:20:28
                8UHC Expansion & Innovative Medicine Position Indonesian Perspective T. Bahdar Johan Hamid Deputy Chairman for Therapeutics Products, Narcotics, Psychotropics and Addictive Substances

                UHC Expansion & Innovative Medicine Position Indonesian Perspective T. Bahdar Johan Hamid Deputy Chairman for Therapeutics Products, Narcotics, Psychotropics and Addictive Substances

                Add to Reading List

                Source URL: apac-asia.com

                Language: English - Date: 2016-05-24 02:04:55
                  9Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated I

                  Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications Candidate to expand Zai Lab’s early-stage R&D programs, with an anticipated I

                  Add to Reading List

                  Source URL: www.crescendobiologics.com

                  Language: English - Date: 2018-05-31 07:22:36
                    1024th MarchMarket and Technology Update Antisense Therapeutics Limited (ASX:ANP or “the Company”) today provides an update on important developments that ANP regard as relevant to its late stage pipeline of ant

                    24th MarchMarket and Technology Update Antisense Therapeutics Limited (ASX:ANP or “the Company”) today provides an update on important developments that ANP regard as relevant to its late stage pipeline of ant

                    Add to Reading List

                    Source URL: www.antisense.com.au

                    Language: English - Date: 2017-03-26 19:47:46